genomiQa brings precision whole genome analytics to routine clinical practice – making whole genome sequencing the norm, not the exception.
Helping clinicians select the best treatment
CapeDx is the most comprehensive cancer genomic test in the world. Available now for research, NATA accreditation for in Australia expected mid-2020.
Simplifying the diagnostic odyssey
Whole genome analysis and clinical reporting to help patients and their families quickly diagnose potential genetic diseases. Available now for research, NATA accreditation for in Australia expected late-2020.
Bringing whole-genome analysis to clinical research
We can help discover the genomic determinants of response for your new drug to develop novel biomarkers and companion diagnostics.
